|
Disruption is not a dirty word: improving clinical trials with AI
Michelle Gallaher is a reasonably well-known contributor to the Australian biotech, MedTech, and digital health sector. She leads a small cap listed company, Opyl in the application of AI to improve clinical trials.
Opyl is a new generation company that applies artificial intelligence in clinical trials and social media to improve healthcare.
In this episode, learn how AI may be used to enhance clinical trials.
Have you ever wondered how clinical trials have changed over time? This episode will show you how artificial intelligence is used in clinical trials, specifically in participant recruitment and protocol design.
Check out the episode and full show notes here.
Loving the show? Leave us a review, and share it with someone who might get some value from it.
Keen to take your healthtech to the next level? Become a THT+ Member for access to our online community forum, quarterly summits and more exclusive content. For more information visit here. |
.png)
More
Religion & Spirituality
Education
Arts and Design
Health
Fashion & Beauty
Government & Organizations
Kids & family
Music
News & Politics
Science & Medicine
Society & Culture
Sports & Recreation
TV & Film
Technology
Philosophy
Storytelling
Horror and Paranomal
True Crime
Leisure
Travel
Fiction
Crypto
Marketing
History
Comedy
Arts
Games & Hobbies
Business
Motivation